# Observational Study to Evaluate Therapeutic Effectiveness and Safety of Monterizine Cap.

> **NCT04654702** · — · COMPLETED · sponsor: **Hanmi Pharmaceutical Company Limited** · enrollment: 2671 (actual)

## Conditions studied

- Perennial Allergic Rhinitis
- Asthma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04654702
- **Lead sponsor:** Hanmi Pharmaceutical Company Limited
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-11-17
- **Primary completion:** 2020-01-10
- **Final completion:** 2020-07-20
- **Target enrollment:** 2671 (ACTUAL)
- **Last updated:** 2021-11-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04654702

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04654702, "Observational Study to Evaluate Therapeutic Effectiveness and Safety of Monterizine Cap.". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04654702. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*